Evidence mapPaperPMID 33553880Full record

ArticleACS omega2021

Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer Therapy.

Hiwa K Saeed, Yogesh Sutar, Pratikkumar Patel, Roopal Bhat, Sudipta Mallick, Alyssa E Hatada, Dana-Lynn T Koomoa, Ingo Lange, Abhijit A Date

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Targeting the organelle for radiosensitization in cancer radiotherapy.Asian journal of pharmaceutical sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Fluoroquinolone-Based Organic Salts (GUMBOS) with Antibacterial Potential.International journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Hiwa K SaeedDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Yogesh SutarDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Pratikkumar PatelDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Roopal BhatDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Sudipta MallickDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Alyssa E HatadaDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Dana-Lynn T KoomoaDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Ingo LangeDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
Abhijit A DateDepartment of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo Hawaii 96720, United States.
University of Hawaii at Hilo · US

Funding

Research Capacity CoreU54MD007601 · UNIVERSITY OF HAWAII AT MANOA · 2025 to 2025
$5.0M
PATHway for Biomedical Careers ProgramP20GM103466 · UNIVERSITY OF HAWAII AT MANOA · 2025 to 2025
$4.5M
Non-canonical NF-kB signaling in diabetic kidney diseaseP20GM113134 · UNIVERSITY OF HAWAII AT MANOA · 2025 to 2025
$2.7M
NIGMS NIH HHS P20 GM103466NIGMS NIH HHS P20 GM113134NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

Epidemiological evidence has accentuated the repurposing of metformin hydrochloride for cancer treatment. However, the extreme hydrophilicity and poor permeability of metformin hydrochloride are responsible for its poor anticancer activity

Identifiers

PMID33553880
PMCPMC7859945
OpenAlexW3125119000

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.